|

Durvalumab 50 MG/ML Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Imfinzi®, MEDI4736

Pipeline

Phase 2: 1

Top Sponsors

  • Alliance Foundation Trials, LLC.1

Indications

  • Small Cell Lung Cancer (SCLC)1
  • Lung Cancer1
  • Cancer1

Charlottesville, Virginia1 trial

Adjuvant Chemotherapy and Immunotherapy for Completely Resected Small Cell Lung Cancer

University of Virginia Comprehensive Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.